ReviewInternal medicine (Tokyo, Japan)2026

Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β Antibody.

Moeko Noguchi-Shinohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.